efficacy, safety, and acceptability of pimavanserin in parkinson’s disease psychosis
Published 1 year ago • 504 plays • Length 4:28Download video MP4
Download video MP3
Similar videos
-
5:33
psychosis in parkinson's disease: clozapine, quetiapine, and pimavanserin
-
4:51
daniel_weintraub - pimavanserin and parkinson’s disease psychosis
-
6:21
zoltan_mari - pimavanserin and parkinson’s disease psychosis
-
3:44
the efficacy and safety of sep-363856 for parkinson’s disease psychosis
-
8:48
managing psychiatric disturbances in parkinson’s disease
-
2:05
mechanistic complications with atypical antipsychotics for parkinson disease psychosis
-
3:43
taking a symptom-based approach to parkinson disease psychosis
-
14:50
nuplazid® (pimavanserin) - indication, dosing, safety; ( parkenson's diseases psychosis )
-
6:08
e10 - treating parkinson's disease-related psychosis
-
4:24
antipsychotic side effects explained: parkinsonism and eps
-
4:41
treating psychosis in parkinson's patients a delicate balance for physicians
-
4:18
treating psychosis in patients with parkinson's disease
-
3:08
pdf's dr james beck discusses fda approval of nuplazid for symptoms of parkinson's psychosis
-
3:39
treatment options for parkinson’s disease psychosis
-
21:32
parkinson’s-related psychosis with dr. alberto j. espay
-
4:03
clive ballard, md: pimavanserin in patients with dementia-related psychosis
-
1:56
parkinson's psychosis
-
7:52
parkinson’s disease psychosis: a case of delusions, diagnosis and therapeutic management
-
51:38
cognitive impairment and psychosis in parkinson’s disease: a movement disorder doctor explains.